ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Late Effects In Breast Cancer Treatment Found In Study

January 25, 2002

DCPC Board Okays Concept For $10 Mil. Program to Promote Cancer Management In Rural Areas

May 25, 1990

DCT Board Ok’s Grants Program For AIDS Malignancies, Contracts

October 23, 1992

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

New Community Clinical Oncology Programs Aimed At Three Hospital Types; 30 Contracts Possible

November 24, 1978